These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28860749)

  • 1. In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine.
    Li S; Wang XP
    Int J Nanomedicine; 2017; 12():5797-5804. PubMed ID: 28860749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmaceutical characteristics of brucine stealth liposomes].
    Chen J; Wang W; Cai BC; Hu W; Wang LJ
    Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(17):2100-4. PubMed ID: 19066050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine.
    Chen J; Yan GJ; Hu RR; Gu QW; Chen ML; Gu W; Chen ZP; Cai BC
    Int J Nanomedicine; 2012; 7():3567-77. PubMed ID: 22904620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ammonium sulfate gradient loading of brucine into liposomes: effect of phospholipid composition on entrapment efficiency and physicochemical properties in vitro.
    Chen J; Lin A; Chen Z; Wang W; Zhang T; Cai H; Cai B
    Drug Dev Ind Pharm; 2010 Mar; 36(3):245-53. PubMed ID: 19678739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization, and liver targeting evaluation of a novel sustained-release brucine self-assembled micelle mediated by glycyrrhetinic acid.
    Guan Q; Yang H; Xia Z; Li X; Zhang Y; Lin Z; Sun S; Yang Z; Zhou X; Lv S; Wang Y
    J Biomater Appl; 2024 Oct; 39(4):317-331. PubMed ID: 39031074
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetic Study on Brucine in Different Administration Methods of Liposome in Rats].
    Liu RX; Li LM; Wu F; Li AR; Liu XW; Guo JW
    Zhong Yao Cai; 2015 Oct; 38(10):2125-8. PubMed ID: 27254928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro transdermal permeation and penetration properties for transfersomes of brucine].
    Wu Y; Chen J; Fang Y; Dong J
    Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(16):3009-3015. PubMed ID: 28920340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel.
    Gu Z; Chang M; Fan Y; Shi Y; Lin G
    Colloids Surf B Biointerfaces; 2017 Dec; 160():395-405. PubMed ID: 28965079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel.
    Luo LM; Huang Y; Zhao BX; Zhao X; Duan Y; Du R; Yu KF; Song P; Zhao Y; Zhang X; Zhang Q
    Biomaterials; 2013 Jan; 34(4):1102-14. PubMed ID: 23127332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of liposomal brucine and its pharmaceutical/pharmacodynamic characterization.
    Qin XQ; Yuan Y; Liu CS; Wang QY; Shen X; Yang BC
    Acta Pharmacol Sin; 2007 Nov; 28(11):1851-8. PubMed ID: 17959038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization and tissue distribution of brucine stealth liposomes with different lipid composition.
    Li J; Chen J; Cai BC; Yang T
    Pharm Dev Technol; 2013; 18(4):772-8. PubMed ID: 21780866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid composition has significant effect on targeted drug delivery properties of NGR-modified liposomes.
    Chen J; Lin A; Peng P; Wang Y; Gu W; Liu Y
    Drug Deliv; 2016 May; 23(4):1426-33. PubMed ID: 26373704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.
    Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC
    Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of gemcitabine in RGD-modified nanoliposomes improves breast cancer inhibitory activity.
    Cai W; Geng C; Jiang L; Sun J; Chen B; Zhou Y; Yang B; Lu H
    Pharm Dev Technol; 2020 Jun; 25(5):640-648. PubMed ID: 32028816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
    Zhao BJ; Ke XY; Huang Y; Chen XM; Zhao X; Zhao BX; Lu WL; Lou JN; Zhang X; Zhang Q
    J Drug Target; 2011 Jun; 19(5):382-90. PubMed ID: 20677914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
    Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
    Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on safety and pharmacodynamic action of transdermal liposomal brucine].
    Qin X; Yuan Y; Liu C; Wang Q; Shen X; Yang B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Dec; 25(6):1358-63. PubMed ID: 19166209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations.
    Xin Y; Qi Q; Mao Z; Zhan X
    Int J Pharm; 2017 Aug; 528(1-2):47-54. PubMed ID: 28559216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of phospholipid composition on pharmaceutical properties and anti-tumor activity of stealth liposomes containing brucine].
    Chen M; Chen J; Hou T; Fang Y; Sun W; Hu R; Cai B
    Zhongguo Zhong Yao Za Zhi; 2011 Apr; 36(7):864-7. PubMed ID: 21761723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and pharmaceutical/pharmacodynamic evaluation of topical brucine-loaded liposomal hydrogel.
    Wang J; Yuan Y; Liu C; Zhu D; Shen X; Yang B
    J Mater Sci Mater Med; 2009 Oct; 20(10):2075-84. PubMed ID: 19459034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.